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Abstract 
Deregulation of gene expression is one of the main characteristics of cancer cells. The implication of 
microRNAs (miRNAs), a class of small non-coding RNAs implicated in post-transcriptional regulation of gene 
expression, in this process have rapidly become evident. As protein-coding genes, miRNAs can act as tumor 
suppressors or oncogenes (we speak about oncomirs). Recent studies have highlighted the paralogous clusters of 
miRNAs mir-17-92 and mir-106a-363 to be involved in carcinogenesis. It features the importance of a local and 
structural organization of miRNAs with potential impact on cancers. We performed computational predictions of 
structural clusters of miRNAs sharing the same characteristics as the two previously described clusters at the 
human genome scale. We show a functional organization of miRNAs in structural clusters where the predicted 
miRNA targets are enriched for cancer associated genes. On the other hand, we also show co-localization of 
structural clusters of miRNAs with genes involved in signaling pathways known to be disrupted in cancer. Taken 
together, the results provide new insights into the organization of miRNAs in the human genome along with their 
potential impact on carcinogenesis. 
 
Introduction 
MicroRNAs (miRNAs) are a class of endogenous 
~18-25nt-long RNAs involved in post-
transcriptional regulation in animals and plants. 
They play crucial functions in cell physiology and 
ensure plethora of key cellular processes by 
negatively regulating expression of target genes. 
While computational software usually predicts 
miRNAs on a one to one basis, recent studies have 
shown that they can be organized into clusters, 
sharing similar biological functions. Indeed, 
miRNAs can group together along the human 
genome to form stable secondary structures made of 
several hairpins hosting miRNAs in their stems. 
Alignment of miRNA sequences lying within the  
same cluster or in different clusters revealed a 
significant number of miRNA paralogs shared 
among and within clusters, implying an evolution 
process targeting the potentially conserved roles of 
these molecules. In this report, we define structural 
clusters of miRNAs as genomic regions typically 
smaller than 1-2 kb and which folds into a 
secondary structure presenting several hairpins, 
where miRNAs are located on their stems. The 
known miRNA clusters mir-17-92 (Hayashita et al., 
2005) and mir-106a-363 (Landais et al., 2007) 
satisfy such structural conditions, and we looked for 
others having the same characteristics in the human 
genome. Notice that miRNA clusters mir-17-92 and 
mir-106a-363 are known to play a role in human 
tumour development.  
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Figure 1: Structural clusters and structural cluster regions. A: structural cluster, known as mir-17-92, predicted on human 
chromosome 13 from deep-sequencing data. miRNAs validated by the algorithm are highlighted in red. This structural cluster 
was filtered with RepeatMasker. B: Example of a structural cluster region, where two structural clusters (red) are located along 
the chromosome (dark grey) together with their targets. Protein-coding genes are represented in green. miRNAs occurring in a 
structural cluster target genes that are located in the same structural cluster region, as indicated by yellow links. We recall that a 
structural cluster region asks to a structural cluster in the region to be spaced no more than δkb from at least another structural 
cluster in the region, where δ typically corresponds to several hundreds. Each region is defined by adding δkb at each end, from 
the structural clusters at the extremes of the region. The shaded areas (light grey) below the chromosome help to highlight these 
conditions. 
 
We report here the results described in Mathelier 
and Carbone, 2013 by focusing on the potential 
involvement of structural clusters of miRNAs in 
cancer. Using newly developed computational 
methods, we predicted structural clusters of 
miRNAs at the human genome scale. The 
predictions were made using three different 
approaches: (1) finding structural clusters of 
paralogous miRNAs from the genomic sequence 
only, (2) constructing structural clusters of miRNAs 
predicted using small RNA-seq (sRNA-seq) data, 
(3) combining paralogous miRNAs prediction and 
sRNA-seq data. The precursors of miRNAs (pre-
miRNAs) have been predicted using the MIReNA 
tool (Mathelier and Carbone, 2010), which has been 
described as a first-choice when predicting new 
miRNAs in mammals (Li et al., 2012). Predictions 
were validated a posteriori as bona fide miRNAs by 
analysing expected characteristics of miRNAs and 
pre-miRNAs. We highlighted that structural 
clusters of miRNAs co-localized with genes related 
to signal transduction pathways, known to be 
involved in carcinogenesis. Finally, a functional 
analysis of potential targets of the predicted 
miRNAs confirms a regulatory role of most 
predicted miRNAs in structural clusters and 
highlights their potential involvement in cancer. 
I. Overview of predicted miRNA 
structural clusters 
The computational tool developed in Mathelier and 
Carbone, 2013 predicts structural clusters either by 
looking for repeated sequences in palindromic 
regions, by using deep-sequencing reads as 
potential miRNAs forming structural clusters or by 
combining the two kinds of information (see 
Methods section of Mathelier and Carbone, 2013 
for details). While the first strategy is based on the 
human genomic sequence to make predictions, the 
two other strategies are using data coming from the 
small RNA-sequencing technology. We want to 
stress here that the sRNA-seq data sets used are 
mainly derived from cancer cells. Namely, breast 
cancer cells, melanoma and pigment cells, and 
cervical cancer cells were used for predicting 
structural clusters of miRNAs. As the 
computational method development is based on the 
characteristics of the two already known miRNA 
structural clusters, the newly predicted structural 
clusters display similar characteristics to the known 
mir-17-92 and mir-106a-363 clusters. 
When applied to the human genome, we predicted 
416 structural clusters containing 1713 miRNAs 
(see Figure 1 for examples). To validate a posteriori 
the predicted miRNAs as bona fide miRNAs, we 
highlighted that 70% of miRNA predictions based 
on either sequence analysis or deep-sequencing data 
contain seeds (i.e. subsequences corresponding to 
positions 2-8 in the miRNA) identical to known 
miRNAs (see Table 1). The presence of already 
identified seeds in miRNAs of structural clusters 
increases the level of confidence in the predictive 
approach as they represent a signature of target 
prediction (Lewis et al., 2003; Lewis et al., 2007). 
Furthermore, a very large fraction of structural 
cluster sequences predicted from deep-sequencing 
data, and 10% of those predicted using paralogs 
contain at least one known miRNA sequence 
(100% identity is asked) from miRBase; many of 
these miRNAs being human miRNAs. 






Atlas Genet Cytogenet Oncol Haematol. 2014; 18(12) 959 
 
Table 1: Structural cluster predictions on human chromosomes. Predictions are realized with the three paths of the 
algorithm, respectively based on : paralogous sequences (paral), deep sequencing reads (deep) and a combination of the two 
kinds of data (comb). The total number of predicted structural clusters (SCs; total), the number of predicted SCs lying in intronic 
regions (intron), and the number of predicted SCs lying in intergenic regions (inter) are reported for each method. The number of 
known miRNAs (with 100% sequence identity) occurring in predicted SC sequences and the number of SCs containing at least 
one predicted miRNA with same seed as in known miRNAs are also reported (last two columns). (Recall that two miRNAs have 
the same seed if their nucleotides at positions 2-8 are the same.) The number of known miRNAs is computed on the miRBase 
dataset. The number of known human miRNAs is given in parenthesis. The total number of predictions obtained by the three 
methods is reported in the last line. Identical predictions (see Methods in Mathelier and Carbone, 2013) are counted once. Note 
that the table is derived from the original predictions made in Mathelier and Carbone, 2013 by using the hg18 version of the 
human genome. 
 
When considering predictions obtained from 
sRNA-seq data, we discovered 12 structural 
clusters containing miRNAs that are all mapped by 
reads coming from the same deep-sequencing 
experiment: eight structural clusters belong to a 
data set from cervical cancer cells and the others to 
melanoma and pigment cells. Predictions were 
made by combining all sRNA-seq data sets 
together. Note that the known mir-17-92 and mir-
106a-363 structural clusters could only be predicted 
by combining sRNA-seq reads coming from 
multiple experiments. Indeed, miRNAs hosted in 
the stems of the structural clusters appeared to 
overlap with reads from specific experiments. 
Namely, four predicted miRNAs over five in mir-
17-92 and four over six in mir-106a-363 come from 
the same experiment. It highlights that even though 
miRNAs are organized in clusters, their expression 
can be cell-type/tissue specific. This evidence 
supports search criteria that mix together reads 
coming from different experiments. 
Our predictions highlight that most of the 99 
predicted structural clusters are only partially 
processed under specific conditions. Indeed, 75 of 
the 99 predicted structural clusters obtained from 
sRNA-seq contain at least two miRNAs coming 
from the same experimental data set, 22 contain at 
least three, six contain at least four and one contain 
at least five. 
II. miRNA structural clusters co-
localize with genes associated to 
specific signal transduction 
pathways involved in 
carcinogenesis 
We studied whether structural clusters of miRNAs 
were functionally organized along the human 
chromosomes. We hypothesized that genes sharing 
similar biological functions with miRNA clusters 
might co-localize along the human genome, 
allowing for an improved transcriptional effciency. 
To evaluate this hypothesis, we analyzed larger and 
larger regions (of a few million bases) around the 
predicted structural clusters and counted the amount 
of genes, in the regions, involved in specific 
biological pathways. All subclasses and pathways 
from all KEGG's pathways have been analyzed. We 
showed that groups of genes involved in specific 
biological pathways and structural clusters of 
miRNAs co-localize in a statistically significant 
manner along the human chromosomes. For 
instance, immune system diseases and sensory 
system subclasses are highlighted.  
We further explored genes involved in signal 
transduction pathways as they have been 
recurrently shown to be involved in cancer 
development and have been defined as preferential 
targets for cancer therapy (Bode and Dong, 2005; 
Reddy and Couvreur, 2010). While taken all 
together, the signal transduction pathways are not 
significantly co-localizing with structural clusters. 
Nevertheless, some specific pathways are enriched 
in structural cluster regions. Namely, the Wnt (150 
genes, P =0.015), Notch (47 genes, P =0.017), and 
Hedgehog (56 genes, P =0.048) pathways display a 
non-random gene distribution in structural cluster 
regions (see Figure 2). These signal transduction 
pathways were previously pinpointed as prime 
candidates for miRNA-mediated regulation, and 
several examples were reported to suggest miRNAs 
to be generators of graded responses or amplifiers 
in signal pathways, both for single pathways or 
signalling cross-talks (Inui et al., 2010). Notice that 
previous works highlighted the role of the Wnt (see 
Polakis, 2000; Anastas and Moon, 2013 for 
reviews), Notch (Hu et al., 2012; Al-Hussaini et al., 
2012; Lobry et al., 2011), and Hedgehog (Amakye 
et al., 2013; Gupta et al., 2010) pathways in cancer 
development and all three pathways have been 
described as preferred therapeutic targets for cancer 
treatment. 
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Figure 2: Curves relating coverage of structural cluster regions to genes belonging to specific KEGG's pathways: Wnt, 
Notch and Hedgehog. The curve generated by randomly selecting genes is also plotted. Similar curves are reported in the 
Supplementary Material of Mathelier and Carbone, 2013 for all statistically significant analysis of KEGG's subclasses. 
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Figure 3: KEGG pathways containing genes whose 3'UTRs are targeted by some predicted miRNAs. Functional analysis 
is realized on a set of miRNA/3'UTR pairs (see Mathelier and Carbone, 2013). A. KEGG pathways showing a Benjamini 
corrected p-value < 5e-4 are drawn. B. KEGG pathways showing a Benjamini corrected p-value < 0.05 and associated to genes 
co-localizing with structural clusters (p-value < 0.05, see previous section) are drawn. A-B. Each node of the graph represents 
an enriched KEGG pathway where the size of the node is proportional to the number of targeted genes (from 45 to 237 genes in 
A and from 37 to 188 genes in B). The higher the opacity of the nodes, the lower the associated p-value. An edge between two 
nodes indicates that the pathways are sharing genes. The larger the width of the edge, the larger the number of shared genes 
(from 3 to 127 in A and from 4 to 55 in B). Cancer KEGG pathways are painted in red, signaling pathways are painted in green, 
and other pathways are painted in grey. See Mathelier and Carbone, 2013 for a full table reporting also GO terms and PIR 
keywords Swiss-Prot Database analyses. 
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Table 2: Functional analysis of structural clusters. For each pathway, the number of mRNAs in the pathway containing at 
least one target and the number of miRNAs with at least one target in these mRNAs are reported in the last two columns. For the 
set of miRNAs targeting genes associated to a specific pathway, we report the number of structural clusters (SCs) containing at 
least one of the miRNAs in the set (2nd column), the number of SCs with all their miRNAs in the set (3rd column), and the ratio 
of these two numbers (4th column). Pathways with a ratio ≥ 30% (blue) and ≥ 40% (green) are highlighted. In the 2nd and 3rd 
columns, the numbers in parenthesis correspond to structural clusters predicted with deep sequencing data. Pathways 
correspond to those in Figure 3A. See Mathelier and Carbone, 2013 for a full table reporting also GO terms and PIR keywords 
Swiss-Prot Database analyses. 
 
III. miRNAs in structural clusters 
target cancer genes  
We further our functional analysis of miRNAs 
contained in computed structural clusters by 
predicting their potential targets. Using the 
miRanda (John et al., 2004) and PITA (Kertesz et 
al., 2007) tools, we predicted targets for all the 
miRNAs computed in the structural clusters in 
3'UTR and CDS of human genes (see Methods of 
Mathelier and Carbone, 2013 for details). The 
following results have been obtained by using 
predictions from miRanda but very similar results 
are derived from PITA's predictions.  
A Gene Ontology (GO) functional enrichment 
analysis of the genes targeted shows that almost 
half (43%) of the biological processes (BP) GO 
terms associated to miRNA/3'UTR pairs are 
involved in regulation and have the motif 
'regulation of' in their name (see Mathelier and 
Carbone, 2013). It suggests that predicted miRNAs 
might be involved in the degradation of 
transcription factors, as it is the case for the two 
already known miRNAs of chromosome 13 (mir-
17-92 structural cluster) regulating protein E2F1 
and being regulated by c-Myc that also regulates 
E2F1 (O'Donnell et al., 2005).  
When considering KEGG pathways, one of the 
pathways with the most enriched gene set in 
miRNA targets is 'pathways in cancer' (P< 5.4e-9). 
Moreover, we observe 14 pathways corresponding 
to different types of cancer ranked as statistically 
significant among all KEGG pathways (see Figure 
3A and  Oxford Journals). Notice that the 
'melanogenesis' (P< 1.1e-5) and the 'melanoma' (P< 
2.8e-5) pathways are highlighted. These specific 
result needs to be considered in the context of the 
set of sRNA-seq data sets that we used with several 
skin cell derived data. Moreover, 115 miRNAs 
(20%) targeting 3'UTRs associated to 
'melanogenesis' and 'melanoma' over a total of 550 
are contained in structural clusters identified using 
deep sequencing data derived from corresponding 
data sets. The enrichment for targets involved in 
melanogenesis and melanoma associated to 
miRNAs predicted from skin sRNA-seq data 
reinforces our confidence in predicting structural 
clusters of bona fide miRNAs using deep 
sequencing reads. Finally, we observed significant 
enrichment for pathways already known to be 
involved in carcinogenesis like apoptosis or 
important signalling pathways such as P53, Wnt, 
MAPK, Hedgehog, mTOR, VEGF, and Notch (see  
Oxford Journals). Notice the enrichment of 
signaling pathways which have been previously 
highlighted as co-localizing with miRNA structural 
clusters (see Figure 3B), the subsequent results 
show that they are also potential targets of these 
miRNAs. 
Using a more stringent set of predicted targets (by 
lowering the threshold on miRNA/target 
predictions, (see Mathelier and Carbone, 2013 for 
details), we observe a stronger signal with BP GO 
terms associated to 'regulation of' covering >48% of 
terms with P< 0.01 and >45% with P< 0.1 (see  
Oxford Journals). By considering KEGG pathways, 
12 pathways corresponding to different types of 
cancers are highlighted again as statistically 
significant, and this confirms the implication of 
predicted miRNAs in cancer development (see 
Oxford Journals). The pathways 'melanogenesis (P< 
2.4e-4) and 'melanoma' (P< 0.017) as well as several 
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signalling pathways are among the identified ones, 
as already pointed out in the functional analysis of 
structural clusters regions. 
It has been previously shown that miRNAs can also 
target genes by binding to CDS regions and not 
only to 3'UTRs (Tay et al., 2008). Looking for 
target predictions within CDSs, the analysis 
confirmed the observations already pointed out for 
3'UTR targets and highlighted the same statistically 
significant terms on different data sets. From 
KEGG's pathways, we observe 'pathways in cancer' 
as the first highlighted term followed by specific 
cancers, signalling pathways and several 
cardiomyopathies (see Oxford Journals).  
It is important to highlight that the miRNA/targets 
predictions ask for a high miRNA/target binding 
energy and that we observe a tendency for miRNAs 
targeting genes from the same functional class to be 
localized in the same structural clusters (see Table 
2). For instance, when considering structural 
clusters with at least one miRNA targeting genes in 
KEGG 'pathways in cancer' we observe that for 
~50% of these clusters, all the miRNAs are 
targeting genes in these pathways. Furthermore, the 
functional analysis on miRNAs predicted by 
paralogous sequences and by deep-sequencing data 
taken separately, provides comparable results to 
those described earlier in the text. It shows that 
miRNAs predicted from a specific methodology are 
not biasing the functional target analysis. Finally, 
among targets obtained from deep-sequencing data, 
we observe a stronger signal of pathways in 'cancer' 
and 'melanogenesis' obtained for the KEGGs data 
set in agreement with the usage of reads coming 
from melanoma cancer cells. 
Conclusion 
The discovery of structural clusters mir-17-92 and 
mir-106a-363 involved in cancer development 
provided the need for a computational tool that 
helps to characterize potential structural clusters 
within the human chromosomes as new candidates 
for experimental tests. In Mathelier and Carbone, 
2013, we predicted structural cluster of miRNAs. 
Predictions were made following three different 
methodologies: (1) using paralogous miRNAs 
derived from genomic sequence analysis, (2) 
predicting miRNAs/pre-miRNAs using sRNA-seq 
data, and (3) combining the two previous methods. 
Predictions of structural clusters based on deep 
sequencing data are showing that 86% of them 
contain miRNAs with known seeds. We highlighted 
13 new structural clusters whose miRNAs are 
identified by reads occurring either in cervical 
cancer or in melanoma and pigment cells 
experiments. 
We showed that structural cluster regions (i.e. 
genomic regions surrounding structural clusters) are  
enriched for genes involved in cancer-related 
pathways such as the Wnt, Hedgehog, and Notch 
pathways.  
A target genes functional analysis strongly supports 
a regulatory role of most predicted miRNAs and, 
notably, a strong involvement of predicted miRNAs 
in the regulation of cancer pathways.  
Our findings highlight miRNA regulation 
mechanisms (potentially affected by mutation) as 
potential causes of signalling pathway 
disfunctioning. Experiments for testing the in silico 
gene target identification are required. 
Appendix The predictions of structural clusters 
miRNAs were originally made using the hg18 
version of the human genome.  
The localization of the predicted miRNAs/pre-
miRNAs have been lifted over to the hg38 version 
of the human genome and can be found as .bed files 
at  UPMC. 
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